Literature DB >> 15563564

Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.

Ziad A Massy1, Ognen Ivanovski, Thao Nguyen-Khoa, Jesus Angulo, Dorota Szumilak, Nadya Mothu, Olivier Phan, Michel Daudon, Bernard Lacour, Tilman B Drüeke, Martin S Muntzel.   

Abstract

Chronic renal failure (CRF) favors the development of atherosclerosis and excessive calcification of atheromatous lesions. CRF was induced in apolipoprotein E knockout (apoE(-/-)) mice to study (1) a possible acceleration of aortic atherosclerosis, (2) the degree and type of vascular calcification, and (3) factors involved in the calcification process. For creating CRF, 8-wk-old apolipoprotein E gene knockout (apoE(-/-)) mice underwent partial kidney ablation. Control animals underwent sham operation. Aortic atherosclerotic plaques and calcification were evaluated using quantitative morphologic image processing. At 6 wk after nephrectomy, CRF mice had significantly higher serum urea, cholesterol, and triglyceride concentrations than non-CRF controls. The serum levels of advanced oxidation protein products were elevated in the uremic group and were correlated with serum urea levels. Atherosclerotic lesions in thoracic aorta were significantly larger in uremic apoE(-/-) mice than in nonuremic controls. The relative proportion of calcified area to total surface area of both atherosclerotic lesions and lesion-free vascular tissue was increased in aortic root of uremic apoE(-/-) mice when compared with controls. The calcium deposits were made of hydroxyapatite and calcite crystals. In addition, plaques from uremic animals showed a significant increase in collagen content, whereas the degree of macrophage infiltration was comparable in both groups. There was no difference in mean arterial BP. These findings demonstrate that CRF aggravates atherosclerosis in apoE(-/-) mice. Moreover, CRF enhances arterial calcification at both atheromatous intimal sites and atheroma-free medial sites. We anticipate that this experimental model will be useful to test treatment strategies aimed at decreasing the accelerated atherosclerosis and arterial calcification in uremia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15563564     DOI: 10.1681/ASN.2004060495

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  61 in total

Review 1.  Atherosclerosis in CKD: differences from the general population.

Authors:  Tilman B Drüeke; Ziad A Massy
Journal:  Nat Rev Nephrol       Date:  2010-10-26       Impact factor: 28.314

2.  A rat model of chronic kidney disease-mineral bone disorder.

Authors:  Sharon M Moe; Neal X Chen; Mark F Seifert; Rachel M Sinders; Dana Duan; Xianming Chen; Yun Liang; J Scott Radcliff; Kenneth E White; Vincent H Gattone
Journal:  Kidney Int       Date:  2008-09-17       Impact factor: 10.612

3.  Farnesoid X receptor activation prevents the development of vascular calcification in ApoE-/- mice with chronic kidney disease.

Authors:  Shinobu Miyazaki-Anzai; Moshe Levi; Adelheid Kratzer; Tabitha C Ting; Linda B Lewis; Makoto Miyazaki
Journal:  Circ Res       Date:  2010-04-29       Impact factor: 17.367

Review 4.  Mineral metabolism and cardiovascular disease in CKD.

Authors:  Hideki Fujii; Nobuhiko Joki
Journal:  Clin Exp Nephrol       Date:  2017-01-06       Impact factor: 2.801

Review 5.  Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification.

Authors:  Sophie E P New; Elena Aikawa
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

6.  Only minor differences in renal osteodystrophy features between wild-type and sclerostin knockout mice with chronic kidney disease.

Authors:  Daniel Cejka; Diego Parada-Rodriguez; Stefanie Pichler; Rodrig Marculescu; Ina Kramer; Michaela Kneissel; Thomas Gross; Andreas Reisinger; Dieter Pahr; Marie-Claude Monier-Faugere; Martin Haas; Hartmut H Malluche
Journal:  Kidney Int       Date:  2016-08-12       Impact factor: 10.612

Review 7.  The emerging role of phosphate in vascular calcification.

Authors:  Cecilia M Giachelli
Journal:  Kidney Int       Date:  2009-01-14       Impact factor: 10.612

8.  Magnesium supplementation helps to improve carotid intima media thickness in patients on hemodialysis.

Authors:  Faruk Turgut; Mehmet Kanbay; Melike Rusen Metin; Ebru Uz; Ali Akcay; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2008-06-21       Impact factor: 2.370

9.  Urea-induced ROS generation causes insulin resistance in mice with chronic renal failure.

Authors:  Maria D'Apolito; Xueliang Du; Haihong Zong; Alessandra Catucci; Luigi Maiuri; Tiziana Trivisano; Massimo Pettoello-Mantovani; Angelo Campanozzi; Valeria Raia; Jeffrey E Pessin; Michael Brownlee; Ida Giardino
Journal:  J Clin Invest       Date:  2009-12-01       Impact factor: 14.808

10.  Moderate kidney disease inhibits atherosclerosis regression.

Authors:  Manish P Ponda; Irina Barash; Jonathan E Feig; Edward A Fisher; Edward Y Skolnik
Journal:  Atherosclerosis       Date:  2009-10-29       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.